|
ACPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.205630E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.607770E-01 |
| Normal-vs-Stage2 |
2.438200E-01 |
| Normal-vs-Stage3 |
1.235600E-01 |
| Normal-vs-Stage4 |
6.054600E-01 |
| Stage1-vs-Stage2 |
8.963800E-01 |
| Stage1-vs-Stage3 |
3.281400E-01 |
| Stage1-vs-Stage4 |
7.036000E-01 |
| Stage2-vs-Stage3 |
4.189400E-01 |
| Stage2-vs-Stage4 |
7.058000E-01 |
| Stage3-vs-Stage4 |
2.989000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.504000E-02 |
| Normal-vs-AfricanAmerican |
2.403700E-02 |
| Normal-vs-Asian |
7.812000E-01 |
| Caucasian-vs-AfricanAmerican |
3.904800E-01 |
| Caucasian-vs-Asian |
3.785600E-01 |
| AfricanAmerican-vs-Asian |
2.893400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.658000E-02 |
| Normal-vs-Female |
6.862300E-03 |
| Male-vs-Female |
1.131440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.239400E-01 |
| Normal-vs-Extreme_Weight |
5.201400E-01 |
| Normal-vs-Obese |
1.154140E-02 |
| Normal-vs-Extreme_Obese |
2.441800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.965800E-01 |
| Normal_Weight-vs-Obese |
1.180830E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.490200E-01 |
| Extreme_Weight-vs-Obese |
3.191800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.808000E-01 |
| Obese-vs-Extreme_Obese |
6.150600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.769600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.701570E-02 |
| Normal-vs-Age(61-80Yrs) |
1.313410E-01 |
| Normal-vs-Age(81-100Yrs) |
2.849800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.391800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.609610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.791430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.230200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.422200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.537200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.736600E-03 |
| Normal-VS-Type2 PRCC |
2.526600E-01 |
| Normal-VS-KIRP CIMP |
4.296400E-02 |
| Normal-VS-Unclassified PRCC |
3.363600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.11119999447152E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.045800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.024600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.146300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.500100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.150770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.823020E-01 |
| Normal-vs-N1 |
2.210200E-01 |
| Normal-vs-N2 |
5.838400E-01 |
| N0-vs-N1 |
5.951400E-01 |
| N0-vs-N2 |
9.185000E-01 |
| N1-vs-N2 |
7.702400E-01 |
|
|
